Post Polycythemia Vera Myelofibrosis

Also known as: Post polycythaemia vera myelofibrosis / Post-Polycythemia Vera / Post-Polycythaemia Vera / Post-polycythemia Vera (Post-PV) / Post Polycythaemia Myelofibrosis (PPV MF) / Myelofibrosis Due to and Following Polycythemia Vera / Post Polycythemia Myelofibrosis / Post Polycythemia Vera Fibrosis / Post-polycythemia Vera Related Myelofibrosis / Myelofibrosis, Post PV / Post Polycythemia-Vera Myelofibrosis / Post-Polycythemia Vera-Myelofibrosis / Post Polycythemia Vera-myelofibrosis / Post-Polycythemia Vera Myelofibrosis / Post Polycythemia Myelofibrosis (PPV MF) / Post PV MF / Post-PV MF / Post-polycythemia Vera (Post-PV) Myelofibrosis / Post-polycythemia Vera Myelofibrosis (PPV-MF) / Post-Polycythemia Vera-Myelofibrosis (PPV-MF) / Post-Polycythemia Vera Myelofibrosis (Post-PV-MF) / Post-polycythemia Vera Myelofibrosis (Post-PV MF) / Post-Polycythemia Vera MF (Post-PV-MF) / Post-Polycythemia Vera (PV) MF / Myelofibrosis due to and following polycythemia vera (disorder) / Myelofibrosis / Myelosis non-leukemic / Agnogenic myeloid metaplasia / Myelofibrosis (disorder) / Myelosis-non-leukaemic / Myelosis non-leukaemic

DrugDrug NameDrug Description
DB08877RuxolitinibA kinase inhibitor used to treat various types of myelofibrosis, polycythemia vera in patients who have not responded to or cannot tolerate hydroxyurea, and to treat graft-versus-host disease in cases that are refractory to steroid treatment.
DrugDrug NamePhaseStatusCount
DB18454AVID-2001Completed1
DB12588AZD-14801Completed1
DB12001Abemaciclib1Recruiting1
DB01262Decitabine1Withdrawn1
DB17561Nisevokitug1Withdrawn1
DB11697Pacritinib1Not Yet Recruiting1
DB06603Panobinostat1Completed1
DB08877Ruxolitinib1Completed1
DB08877Ruxolitinib1Recruiting1
DB08877Ruxolitinib1Terminated1
DB16322Sabatolimab1Withdrawn1
DB14892Spartalizumab1Withdrawn1
DB11760Talazoparib1Not Yet Recruiting1
DB12638Zelavespib1Terminated2
DB17234Bomedemstat1 / 2Completed1
DB15126IMG-72891 / 2Completed1
DB12784Ilginatinib1 / 2Completed1
DB11763Momelotinib1 / 2Completed2
DB15299Navtemadlin1 / 2Recruiting1
DB08910Pomalidomide1 / 2Active Not Recruiting1
DB08877Ruxolitinib1 / 2Active Not Recruiting1
DB08877Ruxolitinib1 / 2Recruiting2
DB06168Canakinumab2Recruiting1
DB12784Ilginatinib2Recruiting1
DB17545Jaktinib2Completed1
DB11763Momelotinib2Active Not Recruiting1
DB11763Momelotinib2Completed3
DB15299Navtemadlin2Recruiting1
DB11697Pacritinib2Completed1
DB06603Panobinostat2Terminated1
DB08877Ruxolitinib2Completed3
DB08877Ruxolitinib2Terminated1
DB11942Selinexor2Recruiting1
DB15299Navtemadlin2 / 3Recruiting1
DB01406Danazol3Completed1
DB01406Danazol3Recruiting1
DB12500Fedratinib3Active Not Recruiting1
DB12500Fedratinib3Completed1
DB01005Hydroxyurea3Recruiting1
DB12281Luspatercept3Recruiting1
DB11763Momelotinib3Completed3
DB11697Pacritinib3Recruiting1
DB11697Pacritinib3Terminated2
DB14867Parsaclisib3Active Not Recruiting2
DB14867Parsaclisib3Not Yet Recruiting1
DB14867Parsaclisib3Recruiting1
DB17129Pelabresib anhydrous3Active Not Recruiting1
DB08877Ruxolitinib3Active Not Recruiting3
DB08877Ruxolitinib3Completed1
DB08877Ruxolitinib3Not Yet Recruiting1
DB08877Ruxolitinib3Recruiting2
DB08877Ruxolitinib4Completed1
DB12500FedratinibNot AvailableRecruiting2
DB08877RuxolitinibNot AvailableAvailable1